Renalytix (Renalytix) Scaled Net Operating Assets : -0.29 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Renalytix Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Renalytix's operating assets for the quarter that ended in Mar. 2024 was $4.07 Mil. Renalytix's operating liabilities for the quarter that ended in Mar. 2024 was $10.46 Mil. Renalytix's Total Assets for the quarter that ended in Dec. 2023 was $21.87 Mil. Therefore, Renalytix's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -0.29.

Renalytix Scaled Net Operating Assets Historical Data

The historical data trend for Renalytix's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Scaled Net Operating Assets Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Scaled Net Operating Assets

Get a 7-Day Free Trial

-5.60

2.30

0.51

0.02

-0.11

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.11	-0.14	-0.16	0.22	-0.29

Competitive Comparison of Renalytix's Scaled Net Operating Assets

For the Health Information Services subindustry, Renalytix's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's Scaled Net Operating Assets Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Renalytix's Scaled Net Operating Assets falls into.

Renalytix Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Renalytix's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2023 )
=	(Operating Assets (A: Jun. 2023 )	-	Operating Liabilities (A: Jun. 2023 ))	/	Total Assets (A: Jun. 2022 )
=	(5.947	-	11.543)	/	50.065
=	-0.11

where

	Operating Assets		(A: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	30.629	-	24.682
=	5.947

	Operating Liabilities		(A: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	23.662	-	7.526	-	4.593
=	11.543

Renalytix's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(4.065	-	10.461)	/	21.874
=	-0.29

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	8.769	-	4.704
=	4.065

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	19.88	-	4.892	-	4.527
=	10.461

Renalytix Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Renalytix's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (Renalytix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

RNLX:USA RENX:UK 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.